Insights

Expert analysis on trends, outlooks, and scenarios in your market and industry.

Earlier this month, FrontierView, in partnership with International Workplace Group (IWG), held its first APAC executive […]
Market access has become a focus for nearly every multinational pharmaceutical, medical device, and diagnostics company. […]
In 2019, the world economy will enter a third straight year of broad-based global growth. A […]
global economy
Multinational companies have a tremendous opportunity to overcome the economic headwinds that are plaguing commercial performance […]
Currency volatility, competitive pressures, and more price-sensitive customers are pressuring multinational companies’ (MNCs) emerging-market pricing processes and […]
Most companies that operate in emerging markets struggle to effectively use data to run their business. There […]
Thank you for your interest in our Monetizing Value-Added Services report! We are excited to offer […]
Each week FrontierView’s global team shares their view on key media stories, and what the implications […]
How COVID-19 will shape global supply chains
This is part 2 of a blog series on channel transition management. You can read part 1 […]
This is part 1 of a blog series on channel transition management. Keep an eye out […]
Market access has become a focus for nearly every multinational pharmaceutical, medical device, and diagnostics company. […]
Although 2019 looks like a year of solid growth and attractive opportunities for MNCs, it’s also […]
You’re an up-and-coming regional executive at a large multinational, representing an emerging-market or a cluster of […]
FrontierView’s CEO, Richard Leggett Podcast Interview Earlier this week, Richard Leggett, CEO of FrontierView took part […]
new frontiers for strategic planning processes
MNCs’ pricing strategies in emerging markets are being rapidly disrupted by a combination of four forces. […]